BECTON, DICKINSON AND COMPANY (BDX) Operating Margin
- Operating margin · 12 months: Value 10.67%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 10.67% | Operating income / revenue. Period ending 2026-06-30. $2.40B ÷ $22.48B × 100 ≈ 10.67% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 2.40B USD | Operating Income (Loss) |
| Revenue | 22.48B USD | |
| Cost of products and services | 11.93B USD | Cost of Goods and Services Sold |
| Research and development | 1.30B USD | Research and Development Expense |
| Selling, general and administration | 5.55B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.40B | $22.48B | $11.93B | $1.30B | $5.55B | 10.67% |
| 2026-03-31 | $2.48B | $22.23B | $11.75B | $1.27B | $5.45B | 11.14% |
| 2025-12-31 | $2.68B | $21.92B | $11.82B | $1.23B | $5.35B | 12.21% |
| 2025-09-30 | $2.58B | $21.84B | $11.91B | $1.26B | $5.28B | 11.81% |
| 2025-06-30 | $2.50B | $21.39B | $11.77B | $1.25B | $5.17B | 11.71% |
| 2025-03-31 | $2.22B | $20.87B | $11.58B | $1.25B | $5.04B | 10.66% |
| 2024-12-31 | $2.41B | $20.64B | $11.31B | $1.24B | $4.96B | 11.68% |
| 2024-09-30 | $2.40B | $20.18B | $11.05B | $1.19B | $4.86B | 11.88% |
| 2024-06-30 | $2.12B | $19.83B | $11.49B | $1.17B | $4.74B | 10.71% |
| 2024-03-31 | $2.07B | $19.72B | $11.58B | $1.18B | $4.73B | 10.50% |
| 2023-12-31 | $1.97B | $19.49B | $11.43B | $1.21B | $4.75B | 10.08% |
| 2023-09-30 | $2.11B | $19.37B | $11.20B | $1.24B | $4.72B | 10.90% |
| 2023-06-30 | $2.25B | $19.05B | $10.50B | $1.26B | $4.76B | 11.82% |
| 2023-03-31 | $2.24B | $18.81B | $10.30B | $1.27B | $4.72B | 11.90% |
| 2022-12-31 | $2.17B | $18.74B | $10.35B | $1.25B | $4.71B | 11.61% |
| 2022-09-30 | $2.28B | $18.87B | $10.39B | $1.26B | $4.71B | 12.09% |
| 2022-06-30 | $2.72B | $20.07B | $10.79B | $1.38B | $4.96B | 13.56% |
| 2022-03-31 | $2.59B | $20.03B | $10.86B | $1.40B | $5.03B | 12.93% |
| 2021-12-31 | $2.37B | $19.93B | $10.81B | $1.38B | $4.94B | 11.91% |
| 2021-09-30 | $2.80B | $20.25B | $10.82B | $1.34B | $4.87B | 13.82% |
| 2021-06-30 | $2.56B | $19.90B | $10.55B | $1.25B | $4.73B | 12.86% |
| 2021-03-31 | $2.29B | $18.86B | $10.02B | $1.17B | $4.48B | 12.14% |
| 2020-12-31 | $2.22B | $18.21B | $9.88B | $1.12B | $4.35B | 12.22% |
| 2020-09-30 | $1.48B | $17.12B | $9.54B | $1.10B | $4.33B | 8.67% |
| 2020-06-30 | $1.34B | $16.92B | $9.28B | $1.07B | $4.22B | 7.92% |
| 2020-03-31 | $1.61B | $17.41B | $9.36B | $1.09B | $4.32B | 9.23% |
| 2019-12-31 | $1.37B | $17.36B | $9.06B | $1.07B | $4.38B | 7.91% |
| 2019-09-30 | $1.76B | $17.29B | $9.00B | $1.06B | $4.33B | 10.18% |
| 2019-06-30 | $2.21B | $17.11B | $9.00B | $1.07B | $4.34B | 12.94% |
| 2019-03-31 | $2.10B | $17.04B | $8.99B | $1.06B | $4.35B | 12.32% |
| 2018-12-31 | $2.15B | $17.06B | $9.38B | $1.07B | $4.32B | 12.60% |
| 2018-09-30 | $1.50B | $15.98B | $8.72B | $1.01B | $4.01B | 9.37% |
| 2018-06-30 | $1.37B | $14.75B | $8.02B | $948.00M | $3.69B | 9.28% |
| 2018-03-31 | $634.00M | $13.50B | $7.29B | $858.00M | $3.32B | 4.70% |
| 2017-12-31 | $897.00M | $12.25B | $6.21B | $784.00M | $2.99B | 7.32% |
| 2017-09-30 | $1.48B | $12.09B | $6.15B | $774.00M | $2.92B | 12.22% |
| 2017-06-30 | $1.13B | $12.16B | $6.22B | $807.00M | $2.95B | 9.30% |
| 2017-03-31 | $1.87B | $12.32B | $6.34B | $827.00M | $2.96B | 15.17% |
| 2016-12-31 | $1.89B | $12.42B | $6.38B | $823.00M | $2.97B | 15.21% |
| 2016-09-30 | $1.43B | $12.48B | $6.49B | $828.00M | $3.00B | 11.46% |
| 2016-06-30 | $1.63B | $12.31B | $6.44B | $771.00M | $2.97B | 13.23% |
| 2016-03-31 | $1.25B | $12.23B | $6.74B | $743.00M | $2.99B | 10.22% |
| 2015-12-31 | $1.08B | $11.22B | $6.16B | $690.00M | $2.77B | 9.60% |
| 2015-09-30 | $1.07B | $10.28B | $5.59B | $632.00M | $2.56B | 10.45% |
| 2015-06-30 | $1.18B | $9.42B | $5.04B | $577.00M | $2.38B | 12.53% |
| 2015-03-31 | $1.49B | $8.46B | $4.16B | $535.00M | $2.14B | 17.60% |
| 2014-12-31 | $1.58B | $8.48B | $4.17B | $553.00M | $2.16B | 18.59% |
| 2014-09-30 | $1.61B | $8.45B | $4.14B | $550.00M | $2.15B | 19.01% |
| 2014-06-30 | $1.28B | $8.35B | $4.06B | $542.00M | $2.46B | 15.34% |
| 2014-03-31 | $1.24B | $8.24B | $4.01B | $526.00M | $2.47B | 15.05% |
| 2013-12-31 | $1.24B | $8.17B | $3.97B | $502.00M | $2.46B | 15.18% |
| 2013-09-30 | $1.25B | $8.05B | $3.88B | $494.00M | $2.42B | 15.57% |
| 2013-06-30 | $1.57B | $7.92B | $3.84B | $489.44M | $2.03B | 19.78% |
| 2013-03-31 | $1.61B | $7.85B | $3.79B | $483.31M | $1.96B | 20.53% |
| 2012-12-31 | $1.61B | $7.78B | $3.75B | $477.69M | $1.94B | 20.74% |
| 2012-09-30 | $1.56B | $7.71B | $3.76B | $471.75M | $1.92B | 20.21% |
| 2012-06-30 | $1.68B | $7.97B | $3.87B | $475.48M | $1.95B | 21.06% |
| 2012-03-31 | $1.67B | $7.94B | $3.85B | $474.27M | $1.95B | 21.09% |
| 2011-12-31 | $1.71B | $7.87B | $3.80B | $474.89M | $1.89B | 21.70% |
| 2011-09-30 | $1.76B | $7.83B | $3.74B | $476.50M | $1.85B | 22.52% |
| 2011-06-30 | $1.74B | $7.65B | $3.64B | (m) | $1.80B | 22.68% |
| 2011-03-31 | $1.69B | $7.47B | $3.57B | (m) | $1.74B | 22.59% |
| 2010-12-31 | $1.66B | $7.35B | $3.51B | (m) | $1.72B | 22.60% |
| 2010-09-30 | $1.68B | $7.37B | $3.54B | (m) | $1.72B | 22.74% |
| 2010-06-30 | $1.76B | $7.54B | $3.62B | (m) | $1.73B | 23.30% |
| 2010-03-31 | $1.75B | $7.48B | $3.58B | (m) | $1.74B | 23.37% |
| 2009-12-31 | $1.68B | $7.36B | $3.52B | (m) | $1.75B | 22.80% |
| 2009-09-30 | $1.65B | $7.16B | $3.40B | (m) | $1.70B | 23.05% |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | $1.54B | $7.07B | $3.45B | (m) | $1.70B | 21.72% |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-09-30 | $1.18B | $6.28B | $3.03B | (m) | $1.58B | 18.86% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |